A role for calreticulin in the pathogenesis of rheumatoid arthritis

Annals of the New York Academy of Sciences

Volumn 1209, Issue 1, 2010, Pages 91-98

  Holoshitz, Joseph ^a   De Almeida, Denise E ^a   Ling, Song ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Calreticulin; Nitric oxide; Rheumatoid arthritis; Shared epitope; Th17; Treg

Indexed keywords

CALRETICULIN; EPITOPE; INTERLEUKIN 17; NITRIC OXIDE; CD8 ANTIGEN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; DENDRITIC CELL; EPITOPE MAPPING; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD8; ARTHRITIS, RHEUMATOID; CALRETICULIN; CELL DIFFERENTIATION; EPITOPES; HUMANS; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 78049497644     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05745.x     Document Type: Article

References (76)

1. Gold, L.I. et al 2010. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J. 24: 665-683.
2. Kuroki, Y., M. Takahashi & C. Nishitani 2007. Pulmonary collectins in innate immunity of the lung. Cell Microbiol. 9: 1871-1879.
3. Obeid, M. et al 2007. Ecto-calreticulin in immunogenic chemotherapy. Immunol. Rev. 220: 22-34.
4. Tarr, J.M. et al 2010. Extracellular calreticulin is present in the joints of rheumatoid arthritis patients and inhibits FasL (CD95L) mediated apoptosis of T cells. Arthritis Rheum. In press.
5. Yan, Q., J.E. Murphy-Ullrich & Y. Song 2010. Structural insight into the role of thrombospondin-1 binding to calreticulin in calreticulin-induced focal adhesion disassembly. Biochemistry 49: 3685-3694.
6. Basu, S. et al 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
7. Cho, J.H. et al 1999. Activation of human neutrophils by a synthetic anti-microbial peptide, KLKLLLLLKLK-NH2, via cell surface calreticulin. Eur. J. Biochem. 266: 878-885.
8. Gardai, S.J. et al 2003. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115: 13-23.
9. Henson, P.M., D.L. Bratton & V.A. Fadok 2001. The phosphatidylserine receptor: a crucial molecular switch? Nat. Rev. Mol. Cell Biol. 2: 627-633.
10. Luo, X. et al 2003. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. J. Neuroimmunol. 135: 62-71.
11. McGreal, E. & P. Gasque 2002. Structure-function studies of the receptors for complement C1q. Biochem. Soc. Trans. 30: 1010-1014.
12. Zeng, G. et al 2006. Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. J. Immunol. 177: 3582-3589.
13. Ogden, C.A. et al 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194: 781-795.
14. Cho, J.H. et al 2001. Activation of human monocyte cell line U937 via cell surface calreticulin. Cell Stress Chaperones 6: 148-152.
15. Chung, E.Y., S.J. Kim & X.J. Ma 2006. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res. 16: 154-161.
16. Gardai, S.J. et al 2006. Recognition ligands on apoptotic cells: a perspective. J. Leukoc. Biol. 79: 896-903.
17. Savill, J. et al 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
18. Pittoni, V. & G. Valesini 2002. The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev. 1: 154-161.
19. Donnelly, S. et al 2006. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 54: 1543-1556.
20. Eggleton, P. & D.H. Llewellyn 1999. Pathophysiological roles of calreticulin in autoimmune disease. Scand. J. Immunol. 49: 466-473.
21. Gregersen, P.K., J. Silver & R.J. Winchester 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30: 1205-1213.
22. Gorman, J.D. et al 2004. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3, 240 rheumatoid arthritis patients. Arthritis Rheum. 50: 400-412.
23. Silman, A.J. et al 1993. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol. 32: 903-907.
24. Lundstrom, E. et al 2009. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important. Arthritis Rheum. 60: 1597-1603.
25. Karlson, E.W. et al 2010. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 69: 54-60.
26. Turesson, C. et al 2005. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res. Ther. 7: R1386-R1393.
27. Moreno, I. et al 1996. Association of the shared epitope with radiological severity of rheumatoid arthritis. J. Rheumatol. 23: 6-9.
28. Gonzalez-Gay, M.A., C. Garcia-Porrua & A.H. Hajeer 2002. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin. Arthritis Rheum. 31: 355-360.
29. Wucherpfennig, K.W. & J.L. Strominger 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181: 1597-1601.
30. La Cava, A. et al 1997. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J. Clin. Invest. 100: 658-663.
31. Bhayani, H.R. & S.M. Hedrick 1991. The role of polymorphic amino acids of the MHC molecule in the selection of the T cell repertoire. J. Immunol. 146: 1093-1098.
32. Weyand, C.M. et al 1994. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum. 37: 514-520.
33. Tait, B.D. et al 1995. HLA-DRB1*0401 is associated with susceptibility to insulin-dependent diabetes mellitus independently of the DQB1 locus. Eur. J. Immunogenet. 22: 289-297.
34. Korendowych, E. et al 2003. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J. Rheumatol. 30: 96-101.
35. Doherty, D.G. et al 1994. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 19: 609-615.
36. Dorak, M.T. et al 1996. Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia. Int. J. Cancer 65: 134-139.
37. Ollier, W.E. et al 2001. Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis. Immunogenetics 53: 669-673.
38. Rosloniec, E.F. et al 1997. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J. Exp. Med. 185: 1113-1122.
39. Wen, L. et al 2001. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J. Clin. Invest. 107: 871-880.
40. Forsthuber, T.G. et al 2001. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J. Immunol. 167: 7119-7125.
41. Goronzy, J.J. & C.M. Weyand 2005. Rheumatoid arthritis. Immunol. Rev. 204: 55-73.
42. Jawaheer, D. et al 1994. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum. 37: 681-686.
43. Boyington, J.C. & P.D. Sun 2002. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38: 1007-1021.
44. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
45. Holoshitz, J. & S. Ling 2007. Nitric oxide signaling triggered by the rheumatoid arthritis shared epitope: a new paradigm for MHC disease association? Ann. N.Y. Acad. Sci. 1110: 73-83.
46. Ling, S. et al 2006. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum. 54: 3423-3432.
47. Ling, S. et al 2007. The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway. Arthritis Res. Ther. 9: R5 1-12.
48. Ling, S., X. Pi & J. Holoshitz 2007. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J. Immunol. 179: 6359-6367.
49. Ling, S. et al 2010. Identification of the rheumatoid arthritis shared epitope binding site on calreticulin. PLoS ONE. 5: e1 1703.
50. Grant, D.D. et al 2001. Nitric oxide donors induce large-scale deletion mutations in human lymphoblastoid cells: implications for mutations in T-lymphocytes from arthritis patients. Environ. Mol. Mutagen. 38: 261-267.
51. Wang, B. et al 2004. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum. 50: 2995-2303.
52. Yki-Jarvinen, H., R. Bergholm & M. Leirisalo-Repo 2003. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann. Rheum Dis. 62: 630-634.
53. Ables, G.P., N. Hamashima & T. Watanabe 2001. Analysis of genetic factors associated with nitric oxide production in mice. Biochem. Genet. 39: 379-394.
54. Chiba, A. et al 2004. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 50: 305-313.
55. Ding, M. et al 1998. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160: 2560-2564.
56. Weller, A.H. et al 1997. Spontaneous myopathy in the SJL/J mouse: pathology and strength loss. Muscle Nerve 20: 72-82.
57. Nair, J. et al 1998. Etheno adducts in spleen DNA of SJL mice stimulated to overproduce nitric oxide. Carcinogenesis 19: 2081-2084.
58. Gal, A. & G.N. Wogan 1996. Mutagenesis associated with nitric oxide production in transgenic SJL mice. Proc. Natl. Acad. Sci. USA 93: 15102-15107.
59. Tamir, S. et al 1995. Nitric oxide production in relation to spontaneous B cell lymphoma and myositis in SJL mice. Cancer Res. 55: 4391-4397.
60. Schuurhuis, D.H. et al 2006. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140: 53-72.
61. Paust, S. & H. Cantor 2005. Regulatory T cells and autoimmune disease. Immunol. Rev. 204: 195-207.
62. Mellor, A.L. & D.H. Munn 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
63. De Almeida, D.E. et al 2010. Immune dysregulation by the rheumatoid arthritis shared epitope. J. Immunol. 185: 1927-1934.
64. Alberati-Giani, D. et al 1997. Differential regulation of indoleamine 2, 3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells. J. Immunol. 159: 419-426.
65. Hucke, C. et al 2004. Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2, 3-dioxygenase. Infect. Immun. 72: 2723-2730.
66. Thomas, S.R., D. Mohr & R. Stocker 1994. Nitric oxide inhibits indoleamine 2, 3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J. Biol. Chem. 269: 14457-14464.
67. Fallarino, F. et al 2002. Functional expression of indoleamine 2, 3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int. Immunol. 14: 65-68.
68. McGeachy, M.J. & D.J. Cua 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
69. Awasthi, A. & V.K. Kuchroo 2009. Th17 cells: from precursors to players in inflammation and infection. Int. Immunol. 21: 489-498.
70. Chabaud, M. et al 1999. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42: 963-970.
71. Ziolkowska, M. et al 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164: 2832-2838.
72. Tesmer, L.A. et al 2008. Th17 cells in human disease. Immunol. Rev. 223: 87-113.
73. Morgan, M.E. et al 2003. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48: 1452-1460.
74. Nakae, S. et al 2003. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177.
75. Khader, S.A. & A.M. Cooper 2008. IL-23 and IL-17 in tuberculosis. Cytokine 41: 79-83.
76. Quintana, F.J. et al 2008. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.